Conmed (CNMD) Non-Current Deferred Tax Liability (2010 - 2026)

Conmed's Non-Current Deferred Tax Liability history runs 17 years deep, the most recent figure standing at $81.4 million for Q1 2026.

• Quarterly Non-Current Deferred Tax Liability rose 16.33% year-over-year to $81.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.4 million (up 16.33% YoY) and the FY2025 annual result came in at $79.5 million, up 7.36% from the prior year.
• Non-Current Deferred Tax Liability was $81.4 million for Q1 2026 at Conmed, up from $79.5 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $170.4 million in Q4 2022 and bottomed at $60.9 million in Q4 2023.
• A 5-year average of $79.8 million and a median of $69.8 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 91.0% — and 2023, when it slumped 64.26%.
• Conmed's Non-Current Deferred Tax Liability stood at $170.4 million in 2022, then slumped by 64.26% to $60.9 million in 2023, then increased by 21.63% to $74.1 million in 2024, then climbed by 7.36% to $79.5 million in 2025, then gained by 2.32% to $81.4 million in 2026.
• Business Quant data shows CNMD's Non-Current Deferred Tax Liability at $81.4 million in Q1 2026, $79.5 million in Q4 2025, and $74.9 million in Q3 2025.